资讯
The global organ on a chip market was valued at US$ 157.06 million in 2024 and is expected to reach US$ 2,238.28 million by ...
15 小时
Axios on MSNFDA plans to phase out animal testing requirementsZoom in: FDA said its roadmap envisions using computer modeling and AI to predict a drug's behavior and possible side effects ...
Researchers discuss how organoids and organ-on-a-chip technologies are transforming women’s health research. By mimicking ...
A deadly disease is on the rise: dengue, a mosquito-borne virus that already affects millions and is spreading even further ...
Once thought improbable, in vitro human models are demonstrating technological prowess in a growing range of applications.
What is an Organ-on-a-Chip? An organ-on-a-chip is a microfluidic device that simulates the key functions and physiological responses of a specific human organ or organ system on a miniaturized scale.
But new “organs-on-chips” technology is emulating the liver, brain, lungs, intestines, and more on a chip the size of a USB stick. Until now scientists conducted most biomedical research ...
The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.
The Organ-Chip platform is particularly well suited ... Artificial intelligence technology used in the NIS-Elements Denoise.ai module allows simple, rapid and powerful post-acquisition removal ...
According to Research by SNS Insider, Organ-on-a-Chip Market growth is driven by advancements in biotechnology, increasing demand for drug testing alternatives, and rising investments in organ ...
One of the main arguments made for bodyoids is that they could provide spare human organs. There’s a huge shortage of organs ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果